US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

TransCode Therapeutics Inc.

8.98

-0.3300-3.54%

Post-market: 9.110.1300+1.45%19:39 EDT

Volume:14.14K

Turnover:126.60K

Market Cap:8.23M

PE:-0.04

High:9.30

Open:9.30

Low:8.79

Close:9.31

52wk High:46.76

52wk Low:6.08

Shares:916.97K

Float Shares:832.40K

Volume Ratio:1.54

T/O Rate:1.70%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-236.5200

EPS(LYR):-1,317.4218

ROE:-1763.01%

ROA:-232.54%

PB:5.77

PE(LYR):-0.01

Loading ...

Overview Company News Filings

TransCode Therapeutics and Quantum Leap Launch Phase 2a Trial for TTX-MC138 in Colorectal Cancer

Transcode Therapeutics Inc - Phase 2a Trial to Begin in 2026

THOMSON REUTERS

BRIEF-Transcode Therapeutics Expands Executive Team With Appointment Of Dr. Michel Janicot As Senior Development Officer

Transcode Therapeutics Expands Executive Team With Appointment of DR. Michel Janicot as Senior Development Officer

THOMSON REUTERS

Press Release: TransCode Therapeutics Expands Executive Team with Appointment of Dr. Michel Janicot as Senior Development Officer

TransCode Therapeutics Amends Preferred Stock Designation

TransCode Therapeutics Updates SEC Filing to Report CVR Agreement Effective Date and Change in Rights Agent

Transcode Therapeutics Inc - Completes Phase 1a Trial With Ttx-Mc138 in Metastatic Disease at Esmo- SEC Filing

THOMSON REUTERS

Transcode Therapeutics Inc - Safety Primary Endpoint Achieved in Phase 1a Trial - SEC Filing

THOMSON REUTERS

TransCode Therapeutics Advances TTX-MC138 to Phase 2a Trials After Positive Phase 1a Results in Metastatic Disease

Transcode Therapeutics Issues Correction to Series B Preferred Stock Price in SEC Filing

TransCode Makes Bold Bet On Melanoma Vaccine With Polynoma Buyout

Benzinga_recent_news

TransCode Therapeutics Acquires Polynoma and Secures Investment

Transcode Therapeutics Inc trading halted, volatility trading pause

Transcode Therapeutics to acquire Polynoma

TransCode Therapeutics acquires Polynoma and secures 25 million investment from CK Life Sciences

Transcode Therapeutics Inc - Concurrent Equity Investment of $25 Mln From CK Life Sciences Into Transcode

THOMSON REUTERS

Transcode Therapeutics Inc: Philippe Calais Appointed as Transcode's Chief Executive Officer and Remains Chairman

THOMSON REUTERS

Transcode Therapeutics (Rnaz) Announces the Acquisition of Polynoma and a $25 Million Strategic Financing by a Subsidiary of CK Life Sciences to Form a First-in-Class Unique Immuno-Oncology and Metastatic Prevention Oncology Company

THOMSON REUTERS

TransCode Therapeutics Amends Patent License Agreement with Massachusetts General Hospital, Increases Milestone Payments

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/RNAZ/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"RNAZ","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"RNAZ\",,,,,undefined,":{"symbol":"RNAZ","market":"US","secType":"STK","nameCN":"TransCode Therapeutics  Inc.","latestPrice":8.98,"timestamp":1774036800000,"preClose":9.31,"halted":0,"volume":14140,"hourTrading":{"tag":"盘后","latestPrice":9.11,"preClose":8.98,"latestTime":"19:39 EDT","volume":3252,"amount":29219.68,"timestamp":1774049943952,"change":0.13,"changeRate":0.014477,"amplitude":0.014477},"delay":0,"changeRate":-0.035445757250268536,"floatShares":832400,"shares":916968,"eps":-236.52,"marketStatus":"Market Closed","change":-0.33,"latestTime":"03-20 16:00:00 EDT","open":9.3,"high":9.3,"low":8.785,"amount":126599.84581999999,"amplitude":0.055317,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-236.52,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1774252800000},"marketStatusCode":7,"adr":0,"listingDate":1622520000000,"exchange":"NASDAQ","adjPreClose":9.31,"postHourTrading":{"tag":"盘后","latestPrice":9.11,"preClose":8.98,"latestTime":"19:39 EDT","volume":3252,"amount":29219.68,"timestamp":1774049943952,"change":0.13,"changeRate":0.014477,"amplitude":0.014477},"volumeRatio":1.5372996084023804},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"RNAZ\",,,,,undefined,":{"symbol":"RNAZ","floatShares":832400,"roa":"-232.54%","roe":"-1763.01%","lyrEps":-1317.421843,"volumeRatio":1.5372996084023804,"shares":916968,"dividePrice":0,"high":9.3,"amplitude":0.055317,"preClose":9.31,"low":8.785,"week52Low":6.0829,"pbRate":"5.77","week52High":46.76,"institutionHeld":0,"latestPrice":8.98,"eps":-236.52,"divideRate":0,"volume":14140,"delay":0,"ttmEps":-236.52,"open":9.3,"prevYearClose":6.83,"prevWeekClose":9.785,"prevMonthClose":9.61,"prevQuarterClose":6.83,"fiveDayClose":9.785,"twentyDayClose":9.69,"sixtyDayClose":7.595},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/RNAZ\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-05-15","symbol":"RNAZ","defaultRemindTime":1747315800000,"type":"split","dateTimestamp":1747281600000,"forFactor":28,"toFactor":1,"ratio":28},{"market":"US","date":"2024-12-04","symbol":"RNAZ","defaultRemindTime":1733322600000,"type":"split","dateTimestamp":1733288400000,"forFactor":33,"toFactor":1,"ratio":33},{"market":"US","date":"2024-01-16","symbol":"RNAZ","defaultRemindTime":1705415400000,"type":"split","dateTimestamp":1705381200000,"forFactor":40,"toFactor":1,"ratio":40},{"market":"US","date":"2023-05-23","symbol":"RNAZ","defaultRemindTime":1684848600000,"type":"split","dateTimestamp":1684814400000,"forFactor":20,"toFactor":1,"ratio":20},{"market":"US","date":"2021-08-23","symbol":"RNAZ","fiscalQuarterEnding":"2021/06","expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1629691200000,"reportTimeType":"","actualEps":0.51}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"RNAZ\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"RNAZ\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/RNAZ\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"RNAZ","date":"2026-03-20","current":-0.037967,"percent":0.639316,"low":-14.365299,"twenty":-4.542375,"median":-0.383263,"eighty":-0.237417,"high":-0.024019,"avg":-1.951475,"sd":3.050026,"marketCap":8536916},"quantilePoints":[{"date":"2021-04-30","current":-14.365299,"twenty":-14.365299,"median":-14.365299,"eighty":-14.365299,"marketCap":33670724},{"date":"2021-05-07","current":-14.365299,"twenty":-14.365299,"median":-14.365299,"eighty":-14.365299,"marketCap":33670724},{"date":"2021-05-11","current":-14.365299,"twenty":-14.365299,"median":-14.365299,"eighty":-14.365299,"marketCap":33670724},{"date":"2021-06-18","current":-2.6923,"twenty":-14.365299,"median":-14.365299,"eighty":-4.960352,"marketCap":18275252},{"date":"2021-06-22","current":-7.012211,"twenty":-14.365299,"median":-14.365299,"eighty":-5.781096,"marketCap":47598684},{"date":"2021-07-09","current":-9.273649,"twenty":-14.365299,"median":-14.365299,"eighty":-7.012211,"marketCap":62949259},{"date":"2021-07-16","current":-5.64483,"twenty":-14.365299,"median":-10.29042,"eighty":-6.205807,"marketCap":38316940},{"date":"2021-07-23","current":-5.942849,"twenty":-14.365299,"median":-7.012211,"eighty":-5.416933,"marketCap":40339884},{"date":"2021-07-30","current":-5.101383,"twenty":-14.365299,"median":-7.012211,"eighty":-5.101383,"marketCap":34628042},{"date":"2021-08-06","current":-5.574708,"twenty":-14.365299,"median":-6.205807,"eighty":-5.136444,"marketCap":37840953},{"date":"2021-08-13","current":-5.031261,"twenty":-14.365299,"median":-5.811369,"eighty":-5.136444,"marketCap":34152055},{"date":"2021-08-20","current":-4.768303,"twenty":-14.365299,"median":-5.714952,"eighty":-5.066322,"marketCap":32367105},{"date":"2021-08-27","current":-10.254026,"twenty":-14.365299,"median":-5.811369,"eighty":-5.083853,"marketCap":39886816},{"date":"2021-09-03","current":-8.929933,"twenty":-11.30719,"median":-6.205807,"eighty":-5.09963,"marketCap":34736270},{"date":"2021-09-10","current":-9.261701,"twenty":-10.464659,"median":-7.012211,"eighty":-5.101032,"marketCap":36026802},{"date":"2021-09-17","current":-8.037833,"twenty":-10.121716,"median":-7.012211,"eighty":-5.129432,"marketCap":31266117},{"date":"2021-09-24","current":-12.106366,"twenty":-10.464659,"median":-7.99392,"eighty":-5.178518,"marketCap":47092176},{"date":"2021-10-01","current":-9.460165,"twenty":-10.702816,"median":-8.236298,"eighty":-5.217085,"marketCap":36798804},{"date":"2021-10-08","current":-9.096313,"twenty":-10.445875,"median":-8.533995,"eighty":-5.308243,"marketCap":35383466},{"date":"2021-10-15","current":-10.650956,"twenty":-10.598032,"median":-8.782076,"eighty":-5.399402,"marketCap":41430822},{"date":"2021-10-22","current":-9.096313,"twenty":-10.598032,"median":-9.096313,"eighty":-5.459006,"marketCap":35383466},{"date":"2021-10-29","current":-9.360933,"twenty":-10.558339,"median":-9.12939,"eighty":-5.483549,"marketCap":36412803},{"date":"2021-11-05","current":-10.849421,"twenty":-10.750188,"median":-9.228623,"eighty":-5.543153,"marketCap":42202825},{"date":"2021-11-12","current":-9.757863,"twenty":-10.750188,"median":-9.261701,"eighty":-5.557177,"marketCap":37956809},{"date":"2021-11-19","current":-7.259636,"twenty":-10.670802,"median":-9.228623,"eighty":-5.571202,"marketCap":35177810},{"date":"2021-11-26","current":-7.153268,"twenty":-10.611263,"median":-9.162468,"eighty":-5.616781,"marketCap":34662385},{"date":"2021-12-03","current":-7.17986,"twenty":-10.564954,"median":-9.096313,"eighty":-5.686903,"marketCap":34791241},{"date":"2021-12-10","current":-7.153268,"twenty":-10.472337,"median":-8.831693,"eighty":-5.735989,"marketCap":34662385},{"date":"2021-12-17","current":-6.860756,"twenty":-10.419413,"median":-8.60015,"eighty":-5.781568,"marketCap":33244964},{"date":"2021-12-23","current":-7.126676,"twenty":-10.353258,"median":-8.451301,"eighty":-5.809616,"marketCap":34533528},{"date":"2021-12-31","current":-6.754387,"twenty":-10.227564,"median":-8.037833,"eighty":-5.869221,"marketCap":32729538},{"date":"2022-01-07","current":-6.461874,"twenty":-10.148178,"median":-7.959179,"eighty":-6.048032,"marketCap":31312117},{"date":"2022-01-14","current":-6.674611,"twenty":-10.075407,"median":-7.764886,"eighty":-6.28696,"marketCap":32342968},{"date":"2022-01-21","current":-5.398191,"twenty":-10.035714,"median":-7.658518,"eighty":-5.961559,"marketCap":26157859},{"date":"2022-01-28","current":-6.036401,"twenty":-9.943097,"median":-7.405893,"eighty":-5.890049,"marketCap":29250414},{"date":"2022-02-04","current":-6.435282,"twenty":-9.890173,"median":-7.259636,"eighty":-5.961559,"marketCap":31183260},{"date":"2022-02-11","current":-5.517856,"twenty":-9.883557,"median":-7.233044,"eighty":-5.961559,"marketCap":26737713},{"date":"2022-02-18","current":-5.850257,"twenty":-9.85048,"median":-7.17986,"eighty":-5.855575,"marketCap":28348419},{"date":"2022-02-25","current":-5.797072,"twenty":-9.824018,"median":-7.17986,"eighty":-5.802604,"marketCap":28090706},{"date":"2022-03-04","current":-5.956625,"twenty":-9.824018,"median":-7.139972,"eighty":-5.750013,"marketCap":28863844},{"date":"2022-03-11","current":-6.328914,"twenty":-9.757863,"median":-7.012211,"eighty":-5.750013,"marketCap":30667835},{"date":"2022-03-18","current":-6.780979,"twenty":-9.757863,"median":-7.012211,"eighty":-5.743888,"marketCap":32858394},{"date":"2022-03-25","current":-6.54165,"twenty":-9.757863,"median":-6.91394,"eighty":-5.750013,"marketCap":31698686},{"date":"2022-04-01","current":-5.336521,"twenty":-9.757863,"median":-6.953828,"eighty":-5.743888,"marketCap":36519944},{"date":"2022-04-08","current":-5.713661,"twenty":-9.757863,"median":-6.91394,"eighty":-5.690704,"marketCap":39100859},{"date":"2022-04-14","current":-5.406292,"twenty":-9.757863,"median":-6.887347,"eighty":-5.660256,"marketCap":36997413},{"date":"2022-04-22","current":-5.072524,"twenty":-9.704939,"median":-6.840812,"eighty":-5.571315,"marketCap":34713304},{"date":"2022-04-29","current":-5.147952,"twenty":-9.58586,"median":-6.780979,"eighty":-5.549313,"marketCap":35229487},{"date":"2022-05-06","current":-5.214864,"twenty":-9.480012,"median":-6.767683,"eighty":-5.483549,"marketCap":35687393},{"date":"2022-05-13","current":-4.266707,"twenty":-9.460165,"median":-6.754387,"eighty":-5.429601,"marketCap":29198776},{"date":"2022-05-20","current":-4.475575,"twenty":-9.407241,"median":-6.674611,"eighty":-5.404672,"marketCap":26084240},{"date":"2022-05-27","current":-4.074778,"twenty":-9.39401,"median":-6.674611,"eighty":-5.336521,"marketCap":23748338},{"date":"2022-06-03","current":-3.941178,"twenty":-9.374164,"median":-6.621427,"eighty":-5.324634,"marketCap":22969704},{"date":"2022-06-10","current":-3.629447,"twenty":-9.360933,"median":-6.54165,"eighty":-5.272407,"marketCap":21152891},{"date":"2022-06-17","current":-2.671985,"twenty":-9.308563,"median":-6.488466,"eighty":-5.22381,"marketCap":15572680},{"date":"2022-06-24","current":-2.850118,"twenty":-9.26887,"median":-6.461874,"eighty":-5.199367,"marketCap":16610859},{"date":"2022-07-01","current":-2.761052,"twenty":-9.261701,"median":-6.435282,"eighty":-5.137471,"marketCap":16091770},{"date":"2022-07-08","current":-3.094827,"twenty":-9.261701,"median":-6.40869,"eighty":-5.087008,"marketCap":18037057},{"date":"2022-07-15","current":-2.939184,"twenty":-9.261701,"median":-6.328914,"eighty":-4.996097,"marketCap":17129948},{"date":"2022-07-22","current":-2.872384,"twenty":-9.255085,"median":-6.227473,"eighty":-4.960352,"marketCap":16740631},{"date":"2022-07-29","current":-3.161849,"twenty":-9.222007,"median":-6.116177,"eighty":-4.771809,"marketCap":18427672},{"date":"2022-08-05","current":-3.195249,"twenty":-9.18893,"median":-6.116177,"eighty":-4.618082,"marketCap":18622330},{"date":"2022-08-12","current":-2.872384,"twenty":-9.149237,"median":-6.036401,"eighty":-4.456649,"marketCap":16740631},{"date":"2022-08-19","current":-1.241956,"twenty":-9.096313,"median":-6.023105,"eighty":-4.180624,"marketCap":16481087},{"date":"2022-08-26","current":-1.095268,"twenty":-9.096313,"median":-5.942849,"eighty":-4.079231,"marketCap":14534502},{"date":"2022-09-02","current":-1.163722,"twenty":-9.063037,"median":-5.890145,"eighty":-3.972352,"marketCap":15442908},{"date":"2022-09-09","current":-1.105047,"twenty":-8.929933,"median":-5.850257,"eighty":-3.629447,"marketCap":14664274},{"date":"2022-09-16","current":-1.085489,"twenty":-8.831693,"median":-5.802604,"eighty":-3.228649,"marketCap":14404729},{"date":"2022-09-23","current":-1.007256,"twenty":-8.73246,"median":-5.773542,"eighty":-3.161849,"marketCap":13366551},{"date":"2022-09-30","current":-1.07571,"twenty":-8.666305,"median":-5.743888,"eighty":-3.094827,"marketCap":14274957},{"date":"2022-10-07","current":-1.19306,"twenty":-8.533995,"median":-5.702183,"eighty":-3.02825,"marketCap":15832225},{"date":"2022-10-14","current":-1.086467,"twenty":-8.533995,"median":-5.675947,"eighty":-2.983717,"marketCap":14417706},{"date":"2022-10-21","current":-1.065931,"twenty":-8.368608,"median":-5.641175,"eighty":-2.939184,"marketCap":14145185},{"date":"2022-10-28","current":-0.745956,"twenty":-8.103988,"median":-5.574708,"eighty":-2.894651,"marketCap":9899034},{"date":"2022-11-04","current":-0.567192,"twenty":-8.037833,"median":-5.55746,"eighty":-2.872384,"marketCap":7526795},{"date":"2022-11-11","current":-0.513407,"twenty":-8.004215,"median":-5.517856,"eighty":-2.827851,"marketCap":6813047},{"date":"2022-11-18","current":-0.451599,"twenty":-7.99392,"median":-5.495807,"eighty":-2.761052,"marketCap":6877934},{"date":"2022-11-25","current":-0.416494,"twenty":-7.938335,"median":-5.469022,"eighty":-2.688237,"marketCap":6343271},{"date":"2022-12-02","current":-0.366392,"twenty":-7.856382,"median":-5.430806,"eighty":-1.257602,"marketCap":5580210},{"date":"2022-12-09","current":-0.458075,"twenty":-7.779782,"median":-5.420196,"eighty":-1.200883,"marketCap":6976560},{"date":"2022-12-16","current":-0.366392,"twenty":-7.743612,"median":-5.398191,"eighty":-1.173502,"marketCap":5580210},{"date":"2022-12-23","current":-0.30794,"twenty":-7.674473,"median":-5.355378,"eighty":-1.163722,"marketCap":4689972},{"date":"2022-12-30","current":-0.573446,"twenty":-7.610652,"median":-5.336521,"eighty":-1.150031,"marketCap":8733678},{"date":"2023-01-06","current":-0.540811,"twenty":-7.546831,"median":-5.323472,"eighty":-1.138297,"marketCap":8236650},{"date":"2023-01-13","current":-0.521469,"twenty":-7.477691,"median":-5.27995,"eighty":-1.124606,"marketCap":7942067},{"date":"2023-01-20","current":-0.582393,"twenty":-7.419189,"median":-5.261093,"eighty":-1.107003,"marketCap":8869939},{"date":"2023-01-27","current":-0.651837,"twenty":-7.312821,"median":-5.242595,"eighty":-1.095268,"marketCap":9927584},{"date":"2023-02-03","current":-0.533484,"twenty":-7.302184,"median":-5.214864,"eighty":-1.095268,"marketCap":8125046},{"date":"2023-02-10","current":-0.413256,"twenty":-7.259636,"median":-5.168494,"eighty":-1.077744,"marketCap":6293958},{"date":"2023-02-17","current":-0.545246,"twenty":-7.259636,"median":-5.139011,"eighty":-1.058107,"marketCap":8304190},{"date":"2023-02-24","current":-0.446753,"twenty":-7.259636,"median":-5.101383,"eighty":-1.017035,"marketCap":6804119},{"date":"2023-03-03","current":-0.477921,"twenty":-7.259636,"median":-5.078188,"eighty":-0.987697,"marketCap":7278825},{"date":"2023-03-10","current":-0.414545,"twenty":-7.259636,"median":-5.031261,"eighty":-0.742156,"marketCap":6313590},{"date":"2023-03-17","current":-0.336207,"twenty":-7.206452,"median":-4.969511,"eighty":-0.639737,"marketCap":5120495},{"date":"2023-03-24","current":-0.331428,"twenty":-7.206452,"median":-4.960352,"eighty":-0.630535,"marketCap":5047707},{"date":"2023-03-31","current":-0.351688,"twenty":-7.17986,"median":-4.820895,"eighty":-0.589635,"marketCap":5356266},{"date":"2023-04-06","current":-0.45174,"twenty":-7.17986,"median":-4.766672,"eighty":-0.576377,"marketCap":6880072},{"date":"2023-04-14","current":-0.359623,"twenty":-7.17986,"median":-4.653708,"eighty":-0.562385,"marketCap":6316770},{"date":"2023-04-21","current":-0.3153,"twenty":-7.158586,"median":-4.508975,"eighty":-0.54538,"marketCap":5538236},{"date":"2023-04-28","current":-0.301157,"twenty":-7.153268,"median":-4.453309,"eighty":-0.536142,"marketCap":5289807},{"date":"2023-05-05","current":-0.280887,"twenty":-7.131994,"median":-4.257226,"eighty":-0.526923,"marketCap":4933777},{"date":"2023-05-12","current":-0.26233,"twenty":-7.07881,"median":-4.141578,"eighty":-0.517222,"marketCap":4607813},{"date":"2023-05-19","current":-0.244735,"twenty":-7.033024,"median":-4.108178,"eighty":-0.502627,"marketCap":4628383},{"date":"2023-05-26","current":-0.218865,"twenty":-7.012211,"median":-4.052511,"eighty":-0.493236,"marketCap":4139139},{"date":"2023-06-02","current":-0.177519,"twenty":-7.012211,"median":-4.007978,"eighty":-0.484966,"marketCap":3357207},{"date":"2023-06-09","current":-0.429482,"twenty":-7.012211,"median":-3.952311,"eighty":-0.474116,"marketCap":8122289},{"date":"2023-06-16","current":-0.396344,"twenty":-7.012211,"median":-3.629447,"eighty":-0.464845,"marketCap":7495590},{"date":"2023-06-23","current":-0.238101,"twenty":-7.001114,"median":-3.339982,"eighty":-0.453859,"marketCap":4502917},{"date":"2023-06-30","current":-0.230481,"twenty":-6.961806,"median":-3.228649,"eighty":-0.448691,"marketCap":4358824},{"date":"2023-07-07","current":-0.2181,"twenty":-6.91394,"median":-3.195249,"eighty":-0.438648,"marketCap":4124672},{"date":"2023-07-13","current":-0.26953,"twenty":-6.91394,"median":-3.161849,"eighty":-0.429701,"marketCap":5097302},{"date":"2023-07-21","current":-0.235243,"twenty":-6.91394,"median":-3.106183,"eighty":-0.417426,"marketCap":4448882},{"date":"2023-07-28","current":-0.225719,"twenty":-6.91394,"median":-3.072783,"eighty":-0.413256,"marketCap":4268765},{"date":"2023-08-04","current":-0.17429,"twenty":-6.887347,"median":-3.050516,"eighty":-0.400475,"marketCap":3296135},{"date":"2023-08-11","current":-0.160004,"twenty":-6.887347,"median":-3.02825,"eighty":-0.38961,"marketCap":3025960},{"date":"2023-08-18","current":-0.157995,"twenty":-6.860756,"median":-2.972583,"eighty":-0.383263,"marketCap":2935902},{"date":"2023-08-25","current":-0.188589,"twenty":-6.820867,"median":-2.96145,"eighty":-0.363636,"marketCap":3504416},{"date":"2023-09-01","current":-0.158066,"twenty":-6.780979,"median":-2.939184,"eighty":-0.359623,"marketCap":2937227},{"date":"2023-09-08","current":-0.125363,"twenty":-6.780979,"median":-2.905784,"eighty":-0.354845,"marketCap":2329525},{"date":"2023-09-15","current":-0.080668,"twenty":-6.780979,"median":-2.872384,"eighty":-0.351688,"marketCap":1498998},{"date":"2023-09-22","current":-0.07597,"twenty":-6.780979,"median":-2.870157,"eighty":-0.348588,"marketCap":1411692},{"date":"2023-09-29","current":-0.062714,"twenty":-6.759705,"median":-2.827851,"eighty":-0.342044,"marketCap":1165370},{"date":"2023-10-06","current":-0.071025,"twenty":-6.754387,"median":-2.816718,"eighty":-0.335629,"marketCap":1319806},{"date":"2023-10-13","current":-0.069464,"twenty":-6.754387,"median":-2.761052,"eighty":-0.331116,"marketCap":1290799},{"date":"2023-10-20","current":-0.062018,"twenty":-6.722231,"median":-2.715542,"eighty":-0.328027,"marketCap":1152437},{"date":"2023-10-27","current":-0.064937,"twenty":-6.706276,"median":-2.682142,"eighty":-0.320027,"marketCap":1206680},{"date":"2023-11-03","current":-0.394873,"twenty":-6.674611,"median":-1.281073,"eighty":-0.325669,"marketCap":7337632},{"date":"2023-11-10","current":-0.374108,"twenty":-6.674611,"median":-1.222398,"eighty":-0.328975,"marketCap":6951778},{"date":"2023-11-17","current":-0.266701,"twenty":-6.674611,"median":-1.202839,"eighty":-0.325669,"marketCap":5225374},{"date":"2023-11-24","current":-0.246083,"twenty":-6.674611,"median":-1.19306,"eighty":-0.313052,"marketCap":4821413},{"date":"2023-12-01","current":-0.252341,"twenty":-6.648019,"median":-1.173502,"eighty":-0.301157,"marketCap":4944008},{"date":"2023-12-08","current":-0.257476,"twenty":-6.621427,"median":-1.163722,"eighty":-0.294624,"marketCap":5044616},{"date":"2023-12-15","current":-0.216613,"twenty":-6.594835,"median":-1.158832,"eighty":-0.284581,"marketCap":4244003},{"date":"2023-12-22","current":-0.21277,"twenty":-6.54165,"median":-1.144164,"eighty":-0.278188,"marketCap":4168710},{"date":"2023-12-29","current":-0.219174,"twenty":-6.54165,"median":-1.144164,"eighty":-0.276419,"marketCap":4294198},{"date":"2024-01-05","current":-0.187022,"twenty":-6.536278,"median":-1.134385,"eighty":-0.272473,"marketCap":3664249},{"date":"2024-01-12","current":-0.174212,"twenty":-6.509527,"median":-1.129495,"eighty":-0.267111,"marketCap":3413273},{"date":"2024-01-19","current":-0.034907,"twenty":-6.488466,"median":-1.124606,"eighty":-0.258101,"marketCap":683918},{"date":"2024-01-26","current":-0.245163,"twenty":-6.461874,"median":-1.105047,"eighty":-0.25511,"marketCap":4803378},{"date":"2024-02-02","current":-0.228731,"twenty":-6.461874,"median":-1.100157,"eighty":-0.252387,"marketCap":4481445},{"date":"2024-02-09","current":-0.226015,"twenty":-6.435282,"median":-1.095268,"eighty":-0.249824,"marketCap":4428227},{"date":"2024-02-16","current":-0.222025,"twenty":-6.435282,"median":-1.095268,"eighty":-0.245163,"marketCap":4350044},{"date":"2024-02-23","current":-0.243453,"twenty":-6.435282,"median":-1.085978,"eighty":-0.244479,"marketCap":4769871},{"date":"2024-03-01","current":-0.236277,"twenty":-6.414008,"median":-1.075808,"eighty":-0.242065,"marketCap":4629272},{"date":"2024-03-08","current":-0.244794,"twenty":-6.40869,"median":-1.07082,"eighty":-0.241215,"marketCap":4796151},{"date":"2024-03-15","current":-0.231347,"twenty":-6.37678,"median":-1.054196,"eighty":-0.238072,"marketCap":4532691},{"date":"2024-03-22","current":-0.228698,"twenty":-6.336892,"median":-1.014394,"eighty":-0.236326,"marketCap":4480788},{"date":"2024-03-28","current":-0.227658,"twenty":-6.312959,"median":-1.007207,"eighty":-0.235241,"marketCap":4460421},{"date":"2024-04-05","current":-0.240859,"twenty":-6.270412,"median":-0.835033,"eighty":-0.235103,"marketCap":4466991},{"date":"2024-04-12","current":-0.200193,"twenty":-6.223139,"median":-0.744056,"eighty":-0.234734,"marketCap":3712797},{"date":"2024-04-19","current":-0.157211,"twenty":-6.152029,"median":-0.657161,"eighty":-0.233326,"marketCap":2915642},{"date":"2024-04-26","current":-0.164413,"twenty":-6.116177,"median":-0.637734,"eighty":-0.231025,"marketCap":3049227},{"date":"2024-05-03","current":-0.232846,"twenty":-6.116177,"median":-0.632224,"eighty":-0.230356,"marketCap":4318393},{"date":"2024-05-10","current":-0.438028,"twenty":-6.116177,"median":-0.613536,"eighty":-0.230455,"marketCap":8123710},{"date":"2024-05-17","current":-0.316863,"twenty":-6.116177,"median":-0.589635,"eighty":-0.230455,"marketCap":5404405},{"date":"2024-05-24","current":-0.539673,"twenty":-6.100222,"median":-0.579751,"eighty":-0.230518,"marketCap":9204653},{"date":"2024-05-31","current":-0.636737,"twenty":-6.068311,"median":-0.584621,"eighty":-0.230864,"marketCap":10860166},{"date":"2024-06-07","current":-0.520261,"twenty":-6.036401,"median":-0.582393,"eighty":-0.231361,"marketCap":8873551},{"date":"2024-06-14","current":-0.45814,"twenty":-6.036401,"median":-0.573446,"eighty":-0.231448,"marketCap":7814022},{"date":"2024-06-21","current":-0.396019,"twenty":-6.036401,"median":-0.567192,"eighty":-0.231716,"marketCap":6754494},{"date":"2024-06-28","current":-0.392137,"twenty":-6.025764,"median":-0.562969,"eighty":-0.231716,"marketCap":6688273},{"date":"2024-07-05","current":-0.337043,"twenty":-5.999172,"median":-0.562107,"eighty":-0.231942,"marketCap":5748604},{"date":"2024-07-12","current":-0.37061,"twenty":-5.95387,"median":-0.549375,"eighty":-0.233157,"marketCap":6321122},{"date":"2024-07-15","current":-0.365073,"twenty":-5.951115,"median":-0.545413,"eighty":-0.233467,"marketCap":6226668},{"date":"2024-08-02","current":-0.279596,"twenty":-5.948359,"median":-0.54533,"eighty":-0.233778,"marketCap":4768774},{"date":"2024-08-09","current":-0.261577,"twenty":-5.935159,"median":-0.540811,"eighty":-0.23458,"marketCap":4461446},{"date":"2024-08-16","current":-0.241071,"twenty":-5.914078,"median":-0.535146,"eighty":-0.23458,"marketCap":4316414},{"date":"2024-08-23","current":-0.268168,"twenty":-5.887486,"median":-0.528286,"eighty":-0.2347,"marketCap":4801579},{"date":"2024-08-30","current":-0.268843,"twenty":-5.860894,"median":-0.524747,"eighty":-0.23472,"marketCap":4813665},{"date":"2024-09-06","current":-0.265178,"twenty":-5.850257,"median":-0.520013,"eighty":-0.2347,"marketCap":4748055},{"date":"2024-09-13","current":-0.243964,"twenty":-5.838208,"median":-0.51569,"eighty":-0.234714,"marketCap":4368211},{"date":"2024-09-20","current":-0.3645,"twenty":-5.813123,"median":-0.509454,"eighty":-0.234734,"marketCap":6526418},{"date":"2024-09-27","current":-0.593228,"twenty":-5.800391,"median":-0.508517,"eighty":-0.234734,"marketCap":10621832},{"date":"2024-10-04","current":-0.591107,"twenty":-5.797072,"median":-0.509454,"eighty":-0.234734,"marketCap":10583848},{"date":"2024-10-11","current":-0.70335,"twenty":-5.778248,"median":-0.513407,"eighty":-0.234801,"marketCap":12593570},{"date":"2024-10-18","current":-0.577607,"twenty":-5.747563,"median":-0.519765,"eighty":-0.235036,"marketCap":10342129},{"date":"2024-10-25","current":-0.6264,"twenty":-5.743888,"median":-0.521196,"eighty":-0.235239,"marketCap":11215771},{"date":"2024-10-31","current":-0.486,"twenty":-5.738101,"median":-0.521469,"eighty":-0.235434,"marketCap":8701891},{"date":"2024-11-08","current":-0.453214,"twenty":-5.714694,"median":-0.520013,"eighty":-0.236212,"marketCap":8114859},{"date":"2024-11-15","current":-0.337403,"twenty":-5.70907,"median":-0.51569,"eighty":-0.236289,"marketCap":6041253},{"date":"2024-11-22","current":-0.439549,"twenty":-5.690704,"median":-0.509454,"eighty":-0.236554,"marketCap":6560950},{"date":"2024-11-29","current":-0.402534,"twenty":-5.690704,"median":-0.499775,"eighty":-0.237417,"marketCap":6008448},{"date":"2024-12-06","current":-0.30495,"twenty":-5.675947,"median":-0.496415,"eighty":-0.237718,"marketCap":4551848},{"date":"2024-12-13","current":-0.252723,"twenty":-5.664112,"median":-0.493246,"eighty":-0.237958,"marketCap":3772279},{"date":"2024-12-20","current":-0.134949,"twenty":-5.64483,"median":-0.486,"eighty":-0.236338,"marketCap":2014323},{"date":"2024-12-27","current":-0.136351,"twenty":-5.638982,"median":-0.481763,"eighty":-0.235767,"marketCap":2035251},{"date":"2025-01-03","current":-0.123732,"twenty":-5.621565,"median":-0.477921,"eighty":-0.234835,"marketCap":1846899},{"date":"2025-01-10","current":-0.120227,"twenty":-5.59644,"median":-0.477553,"eighty":-0.234734,"marketCap":1794579},{"date":"2025-01-17","current":-0.117423,"twenty":-5.567922,"median":-0.472095,"eighty":-0.233467,"marketCap":1752723},{"date":"2025-01-24","current":-0.192784,"twenty":-5.557744,"median":-0.467653,"eighty":-0.231448,"marketCap":2877605},{"date":"2025-01-31","current":-0.375492,"twenty":-5.557631,"median":-0.466511,"eighty":-0.231716,"marketCap":5604804},{"date":"2025-02-07","current":-0.530353,"twenty":-5.557177,"median":-0.46549,"eighty":-0.231942,"marketCap":7916351},{"date":"2025-02-14","current":-0.497235,"twenty":-5.549313,"median":-0.466511,"eighty":-0.233157,"marketCap":7422014},{"date":"2025-02-21","current":-0.437063,"twenty":-5.517856,"median":-0.466511,"eighty":-0.234399,"marketCap":6523853},{"date":"2025-02-28","current":-0.117545,"twenty":-5.50456,"median":-0.464726,"eighty":-0.231716,"marketCap":1754547},{"date":"2025-03-07","current":-0.07883,"twenty":-5.50456,"median":-0.459919,"eighty":-0.230702,"marketCap":1176660},{"date":"2025-03-14","current":-0.034611,"twenty":-5.487055,"median":-0.45816,"eighty":-0.230267,"marketCap":516616},{"date":"2025-03-21","current":-0.035917,"twenty":-5.469524,"median":-0.455272,"eighty":-0.228053,"marketCap":536111},{"date":"2025-03-28","current":-0.813147,"twenty":-5.46852,"median":-0.454243,"eighty":-0.227692,"marketCap":12137494},{"date":"2025-04-04","current":-0.722763,"twenty":-5.46852,"median":-0.45814,"eighty":-0.227692,"marketCap":10788365},{"date":"2025-04-11","current":-0.623309,"twenty":-5.430806,"median":-0.459919,"eighty":-0.228053,"marketCap":9303856},{"date":"2025-04-17","current":-0.496779,"twenty":-5.425988,"median":-0.463616,"eighty":-0.228569,"marketCap":8323520},{"date":"2025-04-25","current":-0.55724,"twenty":-5.423723,"median":-0.459919,"eighty":-0.228724,"marketCap":9336534},{"date":"2025-05-02","current":-0.785708,"twenty":-5.418238,"median":-0.464726,"eighty":-0.228973,"marketCap":13164513},{"date":"2025-05-09","current":-0.487863,"twenty":-5.40842,"median":-0.466511,"eighty":-0.23002,"marketCap":8174135},{"date":"2025-05-16","current":-0.249953,"twenty":-5.399811,"median":-0.467234,"eighty":-0.230385,"marketCap":6377185},{"date":"2025-05-23","current":-0.248972,"twenty":-5.388064,"median":-0.465905,"eighty":-0.230022,"marketCap":6352176},{"date":"2025-05-30","current":-0.225447,"twenty":-5.378754,"median":-0.464376,"eighty":-0.228718,"marketCap":5751971},{"date":"2025-06-06","current":-0.235903,"twenty":-5.351607,"median":-0.459919,"eighty":-0.228718,"marketCap":6018729},{"date":"2025-06-13","current":-0.235413,"twenty":-5.336521,"median":-0.45814,"eighty":-0.228912,"marketCap":6006224},{"date":"2025-06-20","current":-0.228061,"twenty":-5.336521,"median":-0.455272,"eighty":-0.228316,"marketCap":5818660},{"date":"2025-06-27","current":-0.26825,"twenty":-5.333625,"median":-0.451995,"eighty":-0.228711,"marketCap":6844011},{"date":"2025-07-03","current":-0.276091,"twenty":-5.326957,"median":-0.451599,"eighty":-0.228791,"marketCap":7044080},{"date":"2025-07-11","current":-0.294062,"twenty":-5.313893,"median":-0.446753,"eighty":-0.229035,"marketCap":7502571},{"date":"2025-07-18","current":-0.328369,"twenty":-5.295036,"median":-0.443773,"eighty":-0.22914,"marketCap":8377870},{"date":"2025-07-25","current":-0.359437,"twenty":-5.27995,"median":-0.438727,"eighty":-0.229679,"marketCap":9170513},{"date":"2025-08-01","current":-0.362704,"twenty":-5.276179,"median":-0.438196,"eighty":-0.230297,"marketCap":9253881},{"date":"2025-08-08","current":-0.348,"twenty":-5.261093,"median":-0.437433,"eighty":-0.230428,"marketCap":8878723},{"date":"2025-08-15","current":-0.36107,"twenty":-5.261093,"median":-0.435462,"eighty":-0.230493,"marketCap":9212197},{"date":"2025-08-22","current":-0.319249,"twenty":-5.253694,"median":-0.433115,"eighty":-0.230574,"marketCap":7853293},{"date":"2025-08-29","current":-0.334839,"twenty":-5.223953,"median":-0.429592,"eighty":-0.230831,"marketCap":8236788},{"date":"2025-09-05","current":-0.355851,"twenty":-5.223379,"median":-0.426621,"eighty":-0.231347,"marketCap":8753671},{"date":"2025-09-12","current":-0.379574,"twenty":-5.214864,"median":-0.418933,"eighty":-0.231381,"marketCap":9337249},{"date":"2025-09-19","current":-0.380591,"twenty":-5.214864,"median":-0.417216,"eighty":-0.231655,"marketCap":9362260},{"date":"2025-09-26","current":-0.336194,"twenty":-5.189036,"median":-0.415471,"eighty":-0.231716,"marketCap":8270135},{"date":"2025-10-03","current":-0.358562,"twenty":-5.147952,"median":-0.413901,"eighty":-0.231716,"marketCap":8820366},{"date":"2025-10-10","current":-0.500903,"twenty":-5.147952,"median":-0.414143,"eighty":-0.232846,"marketCap":12321834},{"date":"2025-10-17","current":-0.505647,"twenty":-5.139011,"median":-0.415392,"eighty":-0.233289,"marketCap":12438550},{"date":"2025-10-24","current":-0.445322,"twenty":-5.136444,"median":-0.417006,"eighty":-0.234399,"marketCap":10954594},{"date":"2025-10-31","current":-0.371102,"twenty":-5.101383,"median":-0.417216,"eighty":-0.2347,"marketCap":9128828},{"date":"2025-11-07","current":-0.314843,"twenty":-5.09963,"median":-0.415471,"eighty":-0.2347,"marketCap":7744915},{"date":"2025-11-14","current":-0.285359,"twenty":-5.083853,"median":-0.414344,"eighty":-0.234734,"marketCap":7019610},{"date":"2025-11-21","current":-0.263004,"twenty":-5.072524,"median":-0.413256,"eighty":-0.234734,"marketCap":7136326},{"date":"2025-11-28","current":-0.313948,"twenty":-5.067562,"median":-0.411836,"eighty":-0.234734,"marketCap":8518632},{"date":"2025-12-05","current":-0.291836,"twenty":-5.038273,"median":-0.403424,"eighty":-0.234734,"marketCap":7918660},{"date":"2025-12-12","current":-0.352135,"twenty":-4.996097,"median":-0.40212,"eighty":-0.234868,"marketCap":9554806},{"date":"2025-12-19","current":-0.265284,"twenty":-4.980397,"median":-0.400432,"eighty":-0.23517,"marketCap":7198198},{"date":"2025-12-26","current":-0.251091,"twenty":-4.967679,"median":-0.398908,"eighty":-0.235241,"marketCap":6813072},{"date":"2026-01-02","current":-0.230813,"twenty":-4.960352,"median":-0.396262,"eighty":-0.234801,"marketCap":6262850},{"date":"2026-01-09","current":-0.267986,"twenty":-4.960352,"median":-0.395503,"eighty":-0.235024,"marketCap":7271508},{"date":"2026-01-16","current":-0.2984,"twenty":-4.925606,"median":-0.392535,"eighty":-0.235219,"marketCap":8096774},{"date":"2026-01-23","current":-0.314959,"twenty":-4.86998,"median":-0.391393,"eighty":-0.235238,"marketCap":8546085},{"date":"2026-01-30","current":-0.354076,"twenty":-4.841932,"median":-0.390649,"eighty":-0.235277,"marketCap":9607469},{"date":"2026-02-06","current":-0.336926,"twenty":-4.782328,"median":-0.389903,"eighty":-0.23551,"marketCap":9142111},{"date":"2026-02-13","current":-0.333884,"twenty":-4.76765,"median":-0.389142,"eighty":-0.235899,"marketCap":9059584},{"date":"2026-02-20","current":-0.350781,"twenty":-4.76504,"median":-0.388794,"eighty":-0.235903,"marketCap":9518065},{"date":"2026-02-27","current":-0.343684,"twenty":-4.740785,"median":-0.38547,"eighty":-0.236196,"marketCap":9325503},{"date":"2026-03-06","current":-0.315297,"twenty":-4.653708,"median":-0.38427,"eighty":-0.236277,"marketCap":8555255},{"date":"2026-03-13","current":-0.331181,"twenty":-4.609175,"median":-0.383567,"eighty":-0.236338,"marketCap":8986227},{"date":"2026-03-20","current":-0.314622,"twenty":-4.542375,"median":-0.383263,"eighty":-0.237417,"marketCap":8536916}],"updateTime":1774112115681},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"RNAZ\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2590351652","title":"TransCode Therapeutics and Quantum Leap Launch Phase 2a Trial for TTX-MC138 in Colorectal Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2590351652","media":"Reuters","labels":["corporation","dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590351652?lang=en_us&edition=fundamental","pubTime":"2025-12-11 21:05","pubTimestamp":1765458332,"startTime":"0","endTime":"0","summary":"TransCode Therapeutics Inc. has announced a new collaboration with Quantum Leap Healthcare Collaborative to evaluate its lead therapeutic candidate, TTX-MC138, as part of the Quantum Leap PRE-I-SPY clinical trial platform. The partnership will launch a Phase 2a dose-expansion clinical trial enrolling up to 45 colorectal cancer patients who are ctDNA positive after standard curative-intent therapy. The trial aims to assess the biological and clinical activity of TTX-MC138 in the Minimal Residual Disease setting, with the goal of improving long-term outcomes and preventing cancer recurrence. This collaboration is expected to accelerate the development of effective, less toxic precision therapies for cancer patients.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, inv","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251211:nNDL6618CT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation,dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","BK4139","RNAZ"],"gpt_icon":0},{"id":"2590516527","title":"Transcode Therapeutics Inc - Phase 2a Trial to Begin in 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2590516527","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590516527?lang=en_us&edition=fundamental","pubTime":"2025-12-11 21:05","pubTimestamp":1765458300,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251211:nTUA9M9ZHZ:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BK4539","RNAZ"],"gpt_icon":0},{"id":"2584952625","title":"BRIEF-Transcode Therapeutics Expands Executive Team With Appointment Of Dr. Michel Janicot As Senior Development Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2584952625","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584952625?lang=en_us&edition=fundamental","pubTime":"2025-11-17 21:05","pubTimestamp":1763384708,"startTime":"0","endTime":"0","summary":"BRIEF-Transcode Therapeutics Expands Executive Team With Appointment Of Dr. Michel Janicot As Senior Development OfficerTranscode Therapeutics Inc RNAZ.O:TRANSCODE THERAPEUTICS EXPANDS EXECUTIVE TEAM ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251117:nTUABLFKNT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","RNAZ","BK4139"],"gpt_icon":0},{"id":"2584625347","title":"Transcode Therapeutics Expands Executive Team With Appointment of DR. Michel Janicot as Senior Development Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2584625347","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584625347?lang=en_us&edition=fundamental","pubTime":"2025-11-17 21:01","pubTimestamp":1763384460,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251117:nTUABLFKNT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4539","RNAZ","BK4139"],"gpt_icon":0},{"id":"2584762597","title":"Press Release: TransCode Therapeutics Expands Executive Team with Appointment of Dr. Michel Janicot as Senior Development Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2584762597","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584762597?lang=en_us&edition=fundamental","pubTime":"2025-11-17 21:01","pubTimestamp":1763384460,"startTime":"0","endTime":"0","summary":"Accomplished drug development leader to advance TransCode's mission of defeating cancer through RNA innovation and translational excellence. BOSTON, Nov. 17, 2025 /PRNewswire/ -- TransCode Therapeutics, Inc. , an immuno-oncology and targeted cancer therapy company with a focus on treating advanced malignancy, announced today the appointment of Dr. Michel Janicot, Ph.D., as consultant Senior Development Officer. Dr. Janicot brings more than 35 years of experience in pharmaceutical research, preclinical, and early clinical drug development across oncology and other therapeutic areas. He will serve initially on a part-time basis.\"Michel's extensive leadership in drug development will strengthen and guide our efforts as TransCode advances its growing oncology pipeline,\" said Philippe P. Calais, Chief Executive Officer of TransCode Therapeutics. \"His expertise in RNA biology and oncology strategy will be instrumental in advancing TTX-MC138 and Seviprotimut-L-- our two lead programs in our m","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4120","BK4139","TISI","BK4539","RNAZ"],"gpt_icon":0},{"id":"2578642369","title":"TransCode Therapeutics Amends Preferred Stock Designation","url":"https://stock-news.laohu8.com/highlight/detail?id=2578642369","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2578642369?lang=en_us&edition=fundamental","pubTime":"2025-10-27 21:28","pubTimestamp":1761571718,"startTime":"0","endTime":"0","summary":"TransCode Therapeutics ( ($RNAZ) ) has provided an update. On October 27, 2025, TransCode Therapeutics amended and restated its Certificate of Desi...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/transcode-therapeutics-amends-preferred-stock-designation?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/transcode-therapeutics-amends-preferred-stock-designation?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BK4539","RNAZ"],"gpt_icon":0},{"id":"2576663064","title":"TransCode Therapeutics Updates SEC Filing to Report CVR Agreement Effective Date and Change in Rights Agent","url":"https://stock-news.laohu8.com/highlight/detail?id=2576663064","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2576663064?lang=en_us&edition=fundamental","pubTime":"2025-10-18 05:09","pubTimestamp":1760735376,"startTime":"0","endTime":"0","summary":"TransCode Therapeutics Inc. has filed Amendment No. 2 to its Current Report on Form 8-K to report the effective date of its Contingent Value Rights  Agreement and to note a change in the rights agent. The executed CVR Agreement with Vstock Transfer, LLC is included as an exhibit in the filing.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Transcode Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on October 17, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251017:nNDL3SPFgQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4539","RNAZ"],"gpt_icon":0},{"id":"2575903992","title":"Transcode Therapeutics Inc - Completes Phase 1a Trial With Ttx-Mc138 in Metastatic Disease at Esmo- SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2575903992","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575903992?lang=en_us&edition=fundamental","pubTime":"2025-10-14 20:13","pubTimestamp":1760444026,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251014:nFWN3VV1FK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BK4539","RNAZ"],"gpt_icon":0},{"id":"2575290391","title":"Transcode Therapeutics Inc - Safety Primary Endpoint Achieved in Phase 1a Trial - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2575290391","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575290391?lang=en_us&edition=fundamental","pubTime":"2025-10-14 20:13","pubTimestamp":1760444026,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251014:nFWN3VV1FK:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["RNAZ","BK4139","BK4539"],"gpt_icon":0},{"id":"2575777297","title":"TransCode Therapeutics Advances TTX-MC138 to Phase 2a Trials After Positive Phase 1a Results in Metastatic Disease","url":"https://stock-news.laohu8.com/highlight/detail?id=2575777297","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575777297?lang=en_us&edition=fundamental","pubTime":"2025-10-14 20:06","pubTimestamp":1760443609,"startTime":"0","endTime":"0","summary":"TransCode Therapeutics Inc. has announced the completion of its Phase 1a clinical trial evaluating TTX-MC138, an investigational inhibitor of microRNA-10b, in patients with metastatic disease. The trial met its primary safety endpoint and established a recommended Phase 2 dose. Sixteen patients were treated across four escalating dose levels, with no significant treatment-related safety events or dose-limiting toxicities observed. The median treatment duration was four months, ranging from two to twelve months, and three patients remain on trial. Preliminary data showed apparent stable disease lasting over four months in 44% of patients. Ongoing data analysis and monitoring are planned, with a final clinical study report, scientific presentations, and publications to be presented in the future. The company plans to advance TTX-MC138 into a Phase 2a clinical trial to further assess efficacy across selected metastatic diseases.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251014:nNDL7J5rzz:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RNAZ","BK4539","BK4139"],"gpt_icon":0},{"id":"2574619972","title":"Transcode Therapeutics Issues Correction to Series B Preferred Stock Price in SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2574619972","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2574619972?lang=en_us&edition=fundamental","pubTime":"2025-10-09 04:14","pubTimestamp":1759954452,"startTime":"0","endTime":"0","summary":"TransCode Therapeutics Inc. issued a correction to its previously filed Form 8-K, amending the reported price per share of Series B Preferred Stock. The company filed Amendment No. 1 to provide the corrected information and replaced the original Investment Agreement with the accurate version.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Transcode Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on October 08, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251008:nNDL7zgPqp:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RNAZ","BK4139","BK4539"],"gpt_icon":0},{"id":"2573221069","title":"TransCode Makes Bold Bet On Melanoma Vaccine With Polynoma Buyout","url":"https://stock-news.laohu8.com/highlight/detail?id=2573221069","media":"Benzinga_recent_news","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2573221069?lang=en_us&edition=fundamental","pubTime":"2025-10-08 22:48","pubTimestamp":1759934880,"startTime":"0","endTime":"0","summary":"TransCode Therapeutics Inc. (NASDAQ: RNAZ) to acquire Polynoma LLC and receive $25 million investment from CK Life Sciences.","market":"us","thumbnail":"https://cdn.benzinga.com/files/images/story/2025/10/08/Pipette-Adding-Fluid-To-One-Of-Several-T.jpeg?optimize=medium&dpr=2&auto=webp&width=240","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/files/images/story/2025/10/08/Pipette-Adding-Fluid-To-One-Of-Several-T.jpeg?optimize=medium&dpr=2&auto=webp&width=240"],"rights":{"source":"benzinga_recent_news","url":"https://www.benzinga.com/m-a/25/10/48102558/transcode-makes-bold-bet-on-melanoma-vaccine-with-polynoma-buyout","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/m-a/25/10/48102558/transcode-makes-bold-bet-on-melanoma-vaccine-with-polynoma-buyout","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_recent_news","symbols":["BK4161","BK4539","CVR","RNAZ","BK4139"],"gpt_icon":0},{"id":"2573092459","title":"TransCode Therapeutics Acquires Polynoma and Secures Investment","url":"https://stock-news.laohu8.com/highlight/detail?id=2573092459","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2573092459?lang=en_us&edition=fundamental","pubTime":"2025-10-08 22:18","pubTimestamp":1759933080,"startTime":"0","endTime":"0","summary":"TransCode Therapeutics ( ($RNAZ) ) has issued an announcement. On October 8, 2025, TransCode Therapeutics announced the acquisition of Polynoma LLC...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/transcode-therapeutics-acquires-polynoma-and-secures-investment?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/transcode-therapeutics-acquires-polynoma-and-secures-investment?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["RNAZ","BK4139","BK4539"],"gpt_icon":0},{"id":"2573929239","title":"Transcode Therapeutics Inc trading halted, volatility trading pause","url":"https://stock-news.laohu8.com/highlight/detail?id=2573929239","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2573929239?lang=en_us&edition=fundamental","pubTime":"2025-10-08 21:40","pubTimestamp":1759930835,"startTime":"0","endTime":"0","summary":"09:39 EDT Transcode Therapeutics (RNAZ) Inc trading halted, volatility trading pause Published first on TheFly – the ultimate source for real-time,...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/transcode-therapeutics-inc-trading-halted-volatility-trading-pause-thefly-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/transcode-therapeutics-inc-trading-halted-volatility-trading-pause-thefly-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["RNAZ","LENZ","BK4139","BK4007","BK4539"],"gpt_icon":0},{"id":"2573923929","title":"Transcode Therapeutics to acquire Polynoma","url":"https://stock-news.laohu8.com/highlight/detail?id=2573923929","media":"TIPRANKS","labels":["merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2573923929?lang=en_us&edition=fundamental","pubTime":"2025-10-08 20:16","pubTimestamp":1759925816,"startTime":"0","endTime":"0","summary":"TransCode Therapeutics (RNAZ) announced that it entered into a definitive agreement to acquire Polynoma, a privately-held biotechnology immuno-onco...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/transcode-therapeutics-to-acquire-polynoma-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/transcode-therapeutics-to-acquire-polynoma-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4539","LENZ","BK4007","RNAZ","BK4139"],"gpt_icon":0},{"id":"2573092844","title":"TransCode Therapeutics acquires Polynoma and secures 25 million investment from CK Life Sciences","url":"https://stock-news.laohu8.com/highlight/detail?id=2573092844","media":"Reuters","labels":["executive","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2573092844?lang=en_us&edition=fundamental","pubTime":"2025-10-08 20:02","pubTimestamp":1759924947,"startTime":"0","endTime":"0","summary":"TransCode Therapeutics has acquired 100% of the issued and outstanding interests of Polynoma from CK Life Sciences, expanding its oncology pipeline. As part of the transaction, CK Life Sciences is making a $25 million strategic equity investment in TransCode. The acquisition brings Polynoma's Phase 3-ready seviprotimut-L, a novel polyvalent shed antigen vaccine for the adjuvant treatment of melanoma, into TransCode's portfolio alongside its microRNA-based candidate, TTX-MC138, which targets microRNA-10b in metastatic cancer. Philippe Calais, PharmD, PhD, has been appointed Chief Executive Officer while remaining Chairman of the Board. Tom Fitzgerald will continue as Chief Financial Officer, and Elizabeth Czerepak, MBA, joins as an independent board member and Chairperson of the Audit Committee. The integration of Polynoma's team is expected to strengthen TransCode's clinical and development capabilities.Disclaimer: This news brief was created by Public Technologies  using generative ar","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251008:nNDL7rMKPn:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","RNAZ","BK1161","BK4539","00775","BK1569"],"gpt_icon":0},{"id":"2573928257","title":"Transcode Therapeutics Inc - Concurrent Equity Investment of $25 Mln From CK Life Sciences Into Transcode","url":"https://stock-news.laohu8.com/highlight/detail?id=2573928257","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2573928257?lang=en_us&edition=fundamental","pubTime":"2025-10-08 20:02","pubTimestamp":1759924943,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251008:nTUA6JJLQC:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4539","BK4139","RNAZ"],"gpt_icon":0},{"id":"2573492825","title":"Transcode Therapeutics Inc: Philippe Calais Appointed as Transcode's Chief Executive Officer and Remains Chairman","url":"https://stock-news.laohu8.com/highlight/detail?id=2573492825","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2573492825?lang=en_us&edition=fundamental","pubTime":"2025-10-08 20:02","pubTimestamp":1759924943,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251008:nTUA6JJLQC:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["RNAZ","BK4539","BK4139"],"gpt_icon":0},{"id":"2573284129","title":"Transcode Therapeutics (Rnaz) Announces the Acquisition of Polynoma and a $25 Million Strategic Financing by a Subsidiary of CK Life Sciences to Form a First-in-Class Unique Immuno-Oncology and Metastatic Prevention Oncology Company","url":"https://stock-news.laohu8.com/highlight/detail?id=2573284129","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2573284129?lang=en_us&edition=fundamental","pubTime":"2025-10-08 20:02","pubTimestamp":1759924943,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251008:nTUA6JJLQC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","RNAZ","BK4539"],"gpt_icon":0},{"id":"2572633663","title":"TransCode Therapeutics Amends Patent License Agreement with Massachusetts General Hospital, Increases Milestone Payments","url":"https://stock-news.laohu8.com/highlight/detail?id=2572633663","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2572633663?lang=en_us&edition=fundamental","pubTime":"2025-10-04 04:16","pubTimestamp":1759522586,"startTime":"0","endTime":"0","summary":"TransCode Therapeutics Inc. announced it has entered into a Second Amendment to its Exclusive Patent License Agreement with The General Hospital Corporation, doing business as Massachusetts General Hospital. The amendment, effective August 15, 2025, updates the timelines for pre-sales requirements related to Patent Family 1 and Patent Family 2 under the agreement. Additionally, the aggregate amount of one-time milestone payments due to the licensor upon the achievement of certain milestones has been increased from $1,550,000 to $2,950,000 for each patent family. The specific amounts for therapeutic product- or process-related milestone payments were also revised. The full text of the amendment will be filed as an exhibit to TransCode Therapeutics' upcoming quarterly report.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251003:nNDL8D9MmQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4539","RNAZ"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":2,"totalSize":40,"code":"91000000","status":"200"}]}}